DIN 02262088 — OVIDREL 250 MCG
OVIDREL is a solution of Choriogonadotropin alfa marketed by EMD SERONO, A DIVISION OF EMD INC., CANADA. The full Choriogonadotropin alfa monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02262088
- Brand name
- OVIDREL
- Active ingredient
- Choriogonadotropin alfa
- Strength
- 250 MCG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- EMD SERONO, A DIVISION OF EMD INC., CANADA
- Health Canada status
- MARKETED
- Drug class
- Gonadotropin (recombinant hCG)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Choriogonadotropin alfa products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02371588 | OVIDREL | 250 MCG | SOLUTION | EMD SERONO, A DIVISION OF EMD INC., CANADA | MARKETED |